Oaktree Specialty Lending (NASDAQ:OCSL – Get Free Report) had its price objective dropped by analysts at Wells Fargo & Company from $15.00 to $14.00 in a report released on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the credit services provider’s stock. Wells Fargo & Company‘s target price would indicate a potential downside of 5.28% from the stock’s current price.
Several other research analysts have also recently commented on OCSL. Keefe, Bruyette & Woods decreased their target price on shares of Oaktree Specialty Lending from $16.50 to $15.00 and set a “market perform” rating for the company in a report on Tuesday, April 8th. JPMorgan Chase & Co. lowered their price objective on shares of Oaktree Specialty Lending from $15.00 to $14.00 and set a “neutral” rating on the stock in a research report on Thursday. One research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $16.00.
View Our Latest Research Report on Oaktree Specialty Lending
Oaktree Specialty Lending Price Performance
Oaktree Specialty Lending (NASDAQ:OCSL – Get Free Report) last announced its earnings results on Tuesday, February 4th. The credit services provider reported $0.54 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.54. Oaktree Specialty Lending had a return on equity of 12.07% and a net margin of 14.75%. The company had revenue of $86.65 million for the quarter, compared to analyst estimates of $91.93 million. During the same period in the previous year, the firm earned $0.57 earnings per share. Oaktree Specialty Lending’s revenue for the quarter was down 11.6% compared to the same quarter last year. Research analysts forecast that Oaktree Specialty Lending will post 2.06 earnings per share for the current year.
Institutional Trading of Oaktree Specialty Lending
Several hedge funds and other institutional investors have recently modified their holdings of the company. Canton Hathaway LLC purchased a new position in Oaktree Specialty Lending in the fourth quarter valued at about $44,000. Spire Wealth Management bought a new stake in shares of Oaktree Specialty Lending in the 4th quarter valued at approximately $68,000. Geneos Wealth Management Inc. acquired a new position in Oaktree Specialty Lending in the fourth quarter worth approximately $93,000. SG Americas Securities LLC bought a new position in Oaktree Specialty Lending during the fourth quarter valued at approximately $106,000. Finally, EMC Capital Management lifted its stake in Oaktree Specialty Lending by 53.2% in the fourth quarter. EMC Capital Management now owns 8,714 shares of the credit services provider’s stock valued at $133,000 after acquiring an additional 3,026 shares during the last quarter. 36.79% of the stock is currently owned by hedge funds and other institutional investors.
About Oaktree Specialty Lending
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies.
See Also
- Five stocks we like better than Oaktree Specialty Lending
- What is a penny stock? A comprehensive guide
- 3 Stocks Just Announced Intentions to Buyback Near 10% of Shares
- Why Are These Companies Considered Blue Chips?
- 3 Industry Behemoths Are Rewarding Investors With Dividend Bumps
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- The Bear Market Has Only Just Started – Here’s Why
Receive News & Ratings for Oaktree Specialty Lending Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Specialty Lending and related companies with MarketBeat.com's FREE daily email newsletter.